228 related articles for article (PubMed ID: 8546422)
21. Technique for injection of botulinum toxin through the flexible nasolaryngoscope.
Rhew K; Fiedler DA; Ludlow CL
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):787-94. PubMed ID: 7991260
[TBL] [Abstract][Full Text] [Related]
22. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
Holzer SE; Ludlow CL
Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
[TBL] [Abstract][Full Text] [Related]
23. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
[TBL] [Abstract][Full Text] [Related]
24. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
[TBL] [Abstract][Full Text] [Related]
25. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
Pham Q; Campbell R; Mattioni J; Sataloff R
J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
[TBL] [Abstract][Full Text] [Related]
26. Value of Laryngeal Electromyography in Spasmodic Dysphonia Diagnosis and Therapy.
Yang Q; Xu W; Li Y; Cheng L
Ann Otol Rhinol Laryngol; 2015 Jul; 124(7):579-83. PubMed ID: 25673120
[TBL] [Abstract][Full Text] [Related]
27. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
28. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
29. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings.
Zwirner P; Murry T; Swenson M; Woodson GE
Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889
[TBL] [Abstract][Full Text] [Related]
30. Histology of nerves and muscles in adductor spasmodic dysphonia.
Chhetri DK; Blumin JH; Vinters HV; Berke GS
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
Miller RH; Woodson GE; Jankovic J
Arch Otolaryngol Head Neck Surg; 1987 Jun; 113(6):603-5. PubMed ID: 3566940
[TBL] [Abstract][Full Text] [Related]
32. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
Adams SG; Hunt EJ; Charles DA; Lang AE
J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
[TBL] [Abstract][Full Text] [Related]
33. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
Meleca RJ; Hogikyan ND; Bastian RW
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
[TBL] [Abstract][Full Text] [Related]
34. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Inagi K; Rodriquez AA; Ford CN; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
[TBL] [Abstract][Full Text] [Related]
35. Increased stability of airflow following botulinum toxin injection.
Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
[TBL] [Abstract][Full Text] [Related]
36. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
[TBL] [Abstract][Full Text] [Related]
37. Treatment of speech and voice disorders with botulinum toxin.
Ludlow CL
JAMA; 1990 Nov; 264(20):2671-5. PubMed ID: 2232044
[No Abstract] [Full Text] [Related]
38. Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.
Rosow DE; Pechman A; Saint-Victor S; Lo K; Lundy DS; Casiano RR
J Voice; 2015 May; 29(3):352-5. PubMed ID: 25242042
[TBL] [Abstract][Full Text] [Related]
39. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
Stong BC; DelGaudio JM; Hapner ER; Johns MM
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
[TBL] [Abstract][Full Text] [Related]
40. Movement Disorders and Voice.
Snow G; Guardiani E
Otolaryngol Clin North Am; 2019 Aug; 52(4):759-767. PubMed ID: 31076164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]